Vaughn B. Himes - 14 Dec 2023 Form 4 Insider Report for Seagen Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Dec 2023, 18:55:41 UTC
Prior SEC filing
13 Nov 2023
Next SEC filing
24 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jennifer Prosba, Attorney-in-Fact

Key filing fact

Vaughn B. Himes filed Form 4 for Seagen Inc. on 15 Dec 2023.

Key facts

  • This page summarizes Vaughn B. Himes's Form 4 filing for Seagen Inc..
  • 32 reported transactions and 30 derivative rows are listed below.
  • Accepted by SEC: 15 Dec 2023, 18:55.

Change

  • Previous filing in this sequence was filed on 13 Nov 2023.
  • Current net transaction value: -$30,765,005.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGEN transaction

Common Stock

Disposed to Issuer

Transaction value
$3,406,146
Shares
-14,874
Change %
-100%
Price
$229.00
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Footnotes
F1, F2
SGEN transaction

Common Stock

Disposed to Issuer

Transaction value
$27,358,859
Shares
-119,471
Change %
-100%
Price
$229.00
Shares after
0
Date
14 Dec 2023
Ownership
by Trust
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-17,662
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
17,662
Exercise price
$44.09
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-34,946
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
34,946
Exercise price
$39.15
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-40,293
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
40,293
Exercise price
$45.30
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-47,844
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
47,844
Exercise price
$46.37
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-1,301
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
1,301
Exercise price
$76.86
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-41,343
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
41,343
Exercise price
$76.86
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-1,333
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
1,333
Exercise price
$72.64
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-41,453
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
41,453
Exercise price
$72.64
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-636
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
636
Exercise price
$161.82
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-15,719
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
15,719
Exercise price
$161.82
Footnotes
F1, F3
SGEN transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-642
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
642
Exercise price
$155.87
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-20,626
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
20,626
Exercise price
$155.87
Footnotes
F1, F3
SGEN transaction Derivative

Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-8,333
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
8,333
Exercise price
$34.20
Footnotes
F1, F3
SGEN transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-1,649
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
1,649
Exercise price
Footnotes
F1, F4
SGEN transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-4,358
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
4,358
Exercise price
Footnotes
F1, F4
SGEN transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-9,010
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
9,010
Exercise price
Footnotes
F1, F4
SGEN transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-1,214
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
1,214
Exercise price
Footnotes
F1, F5
SGEN transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-11,469
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
11,469
Exercise price
Footnotes
F1, F5
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-2,800
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
2,800
Exercise price
Footnotes
F1, F6
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-3,204
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
3,204
Exercise price
Footnotes
F1, F6
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-510
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
510
Exercise price
Footnotes
F1, F6
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-5,091
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
5,091
Exercise price
Footnotes
F1, F6
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-9,745
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
9,745
Exercise price
Footnotes
F1, F6
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-11,085
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
11,085
Exercise price
Footnotes
F1, F6
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-1,275
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
1,275
Exercise price
Footnotes
F1, F6
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-765
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
765
Exercise price
Footnotes
F1, F6
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-1,827
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
1,827
Exercise price
Footnotes
F1, F7
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-1,019
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
1,019
Exercise price
Footnotes
F1, F8
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-2,548
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
2,548
Exercise price
Footnotes
F1, F8
SGEN transaction Derivative

Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-1,529
Change %
-100%
Price
Shares after
0
Date
14 Dec 2023
Ownership
Direct
Underlying class
Common stock
Underlying amount
1,529
Exercise price
Footnotes
F1, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Vaughn B. Himes is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 8 footnotes

Footnote F1

Reflects the disposition of shares of common stock, par value $0.001 per share ("Common Stock"), of Seagen Inc. ("Issuer"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the "Merger Agreement"), by and among the Issuer, Pfizer Inc. ("Parent") and Aris Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the "Merger").

Footnote F2

Pursuant to the Merger Agreement, at the Effective Time, each issued and outstanding share of Common Stock (other than certain excluded shares described in the Merger Agreement) was cancelled and converted automatically into the right to receive cash in an amount equal to $229.00 per share of Common Stock (the "Merger Consideration").

Footnote F3

Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option.

Footnote F4

Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit (each, a "Company RSU"), other than any Post-Signing Company RSU (as defined below), was cancelled and converted into the right to receive an amount in cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Company RSU.

Footnote F5

Pursuant to the Merger Agreement, at the Effective Time, each outstanding Company RSU granted after March 12, 2023 that was unvested as of immediately prior to the Effective Time (each, a "Post-Signing Company RSU") was cancelled and converted into the right to receive a Parent cash-based award subject to service-based vesting requirements with respect to an amount in cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Post-Signing Company RSU.

Footnote F6

Pursuant to the Merger Agreement, at the Effective Time, each outstanding performance-based restricted stock unit (each, a "Company PSU"), other than any Company Products PSU or any Company August 2023 PSU (each, as defined below), was cancelled and converted into the right to receive cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Company PSU, based on the greater of the target and actual performance. Amounts are shown here based on actual performance.

Footnote F7

Pursuant to the Merger Agreement, at the Effective Time, each outstanding "Company Products PSU" (as defined in the Merger Agreement) that was unvested as of immediately prior to the Effective Time was cancelled and converted into the right to receive a Parent cash-based award subject to the same performance-based vesting requirements with respect to an amount in cash that is equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Company Products PSU.

Footnote F8

Pursuant to the Merger Agreement, at the Effective Time, each outstanding performance-based restricted stock unit granted in August 2023 (each, a "Company August 2023 PSU") that was unvested as of immediately prior to the Effective Time, was cancelled and converted into the right to receive a Parent cash-based award with respect to an amount in cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Company August 2023 PSU, based on target performance.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .